This 30-minute webinar focused on the development towards a vaccine for Alzheimer's disease and other types of dementia
This 75-minute discussion follows up from the launch event of the World Alzheimer Report 2022 and focuses on innovations taking place in post-diagnosis support, care and treatment.
This webinar focuses on the concept of telemedicine and its use for care and diagnostics purposes, including examples around its use throughout the COVID-19 pandemic and the challenges that it still presents.
This webinar focuses on the success and lessons of the South Korean example in making dementia a public health priority, with innovative thinking and technology paving the way.
This webinar focuses on the global development and distribution of COVID-19 vaccines, including issues around equitable distribution and disinformation, as well as stories of success.
This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.
This webinar featured a panel discussion with experts from around the world who presented on the areas of dementia risk reduction, NCDs, air pollution, and the lived experience of dementia during COVID-19.
This webinar focuses on key issues emerging around dementia care and palliative care during the COVID-19 pandemic, and crucially how these can be taken forward.